2m 2m 2m 2m 2m 2m 2m
REGENXBIO (RGNX)
NASDAQ
$10.76+$0.04 (+0.36%)
Price as of Aug 21, 2026 7:30 PM EDT- $707.7MMarket Cap
- 18.98%1-Year Change
- BiotechnologyIndustry
REGENXBIO (RGNX)
$10.76+$0.04 (+0.36%)
RGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.72 | ||
Change | -$0.34 (-3.07%) | ||
Open | $11.14 | ||
High | $11.16 | ||
Low | $10.49 | ||
Previous Close | $11.06 | ||
Volume | 1,007,024 | ||
30-Day Average Volume | 1,094,063 | ||
1-Week Change | -0.42% | ||
1-Month Change | 3.68% | ||
1-Year Change | 18.98% | ||
3-Year Change | -40.87% | ||
5-Year Change | -63.82% | ||
Fundamentals | |||
Shares Outstanding | 66.0M | ||
Total Assets | $386.6M | ||
Market Cap | $707.7M | ||
Enterprise Value | $671.2M | ||
Period: QTR TTM FY | |||
Revenue | $103.8M | ||
Net Income | $22.7M | ||
Free Cash Flow | -$63.0M | ||
EBIT | $22.7M | ||
EBITDA | $26.5M | ||
Net Working Capital | $153.5M | ||
EPS | $0.43 | ||
Enterprise Value/EBITDA | 25 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 10 | ||
P/E | 25 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue